Section Arrow
LNSR.NASDAQ
- LENSAR
Quotes are at least 15-min delayed:2026/04/29 04:28 EDT
Pre Market
Last
 --
-- (--)
Bid
5.25
Ask
5.68
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 5.35
+0.14 (+2.69%)
Day High 
5.46 
Prev. Close
5.21 
1-M High
6.5 
Volume 
50.47K 
Bid
5.25
Ask
5.68
Day Low
5.21 
Open
5.21 
1-M Low
5.06 
Market Cap 
63.02M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.59 
20-SMA 5.7 
50-SMA 8.27 
52-W High 14.3099 
52-W Low 5.06 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.87/--
Enterprise Value
65.01M
Balance Sheet
Book Value Per Share
-2.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
58.44M
Operating Revenue Per Share
3.16
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc.0.5553+0.0422+8.22%-- 
Pre Market 0.5471 -0.0082 -1.48%
BSXBoston Scientific Corp58.45-1.5-2.50%30.9PE
Pre Market 58.54 +0.09 +0.15%
ABTAbbott Laboratories93.86+1.06+1.14%24.95PE
Pre Market 94.2838 +0.4238 +0.45%
MDTMedtronic plc81.9-1.02-1.23%23.16PE
Pre Market 81.85 -0.05 -0.06%
ZBHZimmer Biomet Holdings82.8-9.79-10.57%26.08PE
Pre Market 83 +0.2 +0.24%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.